nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—DRD1—autistic disorder	0.437	0.647	CbGaD
Propiomazine—HTR2A—autistic disorder	0.238	0.353	CbGaD
Propiomazine—DRD1—telencephalic ventricle—autistic disorder	0.00686	0.0614	CbGeAlD
Propiomazine—HTR2C—telencephalic ventricle—autistic disorder	0.00533	0.0477	CbGeAlD
Propiomazine—HTR2A—cerebellar cortex—autistic disorder	0.0046	0.0411	CbGeAlD
Propiomazine—DRD2—telencephalic ventricle—autistic disorder	0.00405	0.0362	CbGeAlD
Propiomazine—HTR2A—pons—autistic disorder	0.00325	0.0291	CbGeAlD
Propiomazine—HTR2A—telencephalic ventricle—autistic disorder	0.00267	0.0239	CbGeAlD
Propiomazine—CHRM5—eye—autistic disorder	0.00212	0.019	CbGeAlD
Propiomazine—ADRA1A—hindbrain—autistic disorder	0.00195	0.0175	CbGeAlD
Propiomazine—DRD2—hindbrain—autistic disorder	0.00191	0.0171	CbGeAlD
Propiomazine—ADRA1D—forebrain—autistic disorder	0.00188	0.0168	CbGeAlD
Propiomazine—DRD1—brainstem—autistic disorder	0.00186	0.0166	CbGeAlD
Propiomazine—DRD1—forebrain—autistic disorder	0.00179	0.016	CbGeAlD
Propiomazine—ADRA1D—telencephalon—autistic disorder	0.00173	0.0155	CbGeAlD
Propiomazine—DRD1—telencephalon—autistic disorder	0.00165	0.0147	CbGeAlD
Propiomazine—CHRM4—head—autistic disorder	0.00154	0.0138	CbGeAlD
Propiomazine—DRD4—brain—autistic disorder	0.00148	0.0132	CbGeAlD
Propiomazine—CHRM4—nervous system—autistic disorder	0.00146	0.0131	CbGeAlD
Propiomazine—CHRM2—forebrain—autistic disorder	0.00144	0.0129	CbGeAlD
Propiomazine—HTR2C—brainstem—autistic disorder	0.00144	0.0129	CbGeAlD
Propiomazine—CHRM4—central nervous system—autistic disorder	0.00141	0.0126	CbGeAlD
Propiomazine—HTR2C—forebrain—autistic disorder	0.00139	0.0124	CbGeAlD
Propiomazine—CHRM2—telencephalon—autistic disorder	0.00133	0.0119	CbGeAlD
Propiomazine—CHRM1—forebrain—autistic disorder	0.00131	0.0118	CbGeAlD
Propiomazine—HTR2C—telencephalon—autistic disorder	0.00128	0.0114	CbGeAlD
Propiomazine—HTR2A—hindbrain—autistic disorder	0.00126	0.0113	CbGeAlD
Propiomazine—CHRM1—telencephalon—autistic disorder	0.00121	0.0108	CbGeAlD
Propiomazine—CHRM5—head—autistic disorder	0.0012	0.0108	CbGeAlD
Propiomazine—CHRM3—forebrain—autistic disorder	0.00118	0.0105	CbGeAlD
Propiomazine—CHRM5—nervous system—autistic disorder	0.00114	0.0102	CbGeAlD
Propiomazine—ADRA1A—brainstem—autistic disorder	0.00112	0.01	CbGeAlD
Propiomazine—CHRM4—brain—autistic disorder	0.00112	0.00999	CbGeAlD
Propiomazine—ADRA1B—head—autistic disorder	0.0011	0.00984	CbGeAlD
Propiomazine—CHRM5—central nervous system—autistic disorder	0.0011	0.00983	CbGeAlD
Propiomazine—DRD2—brainstem—autistic disorder	0.0011	0.00981	CbGeAlD
Propiomazine—CHRM3—telencephalon—autistic disorder	0.00108	0.00967	CbGeAlD
Propiomazine—ADRA1A—forebrain—autistic disorder	0.00108	0.00966	CbGeAlD
Propiomazine—ADRA1D—head—autistic disorder	0.00108	0.00963	CbGeAlD
Propiomazine—DRD2—eye—autistic disorder	0.00107	0.00955	CbGeAlD
Propiomazine—DRD2—forebrain—autistic disorder	0.00106	0.00947	CbGeAlD
Propiomazine—ADRA1B—nervous system—autistic disorder	0.00104	0.00933	CbGeAlD
Propiomazine—DRD1—head—autistic disorder	0.00103	0.00917	CbGeAlD
Propiomazine—ADRA1D—nervous system—autistic disorder	0.00102	0.00913	CbGeAlD
Propiomazine—ADRA1B—central nervous system—autistic disorder	0.001	0.00898	CbGeAlD
Propiomazine—ADRA1A—telencephalon—autistic disorder	0.000993	0.00888	CbGeAlD
Propiomazine—ADRA1D—central nervous system—autistic disorder	0.000983	0.00879	CbGeAlD
Propiomazine—DRD2—telencephalon—autistic disorder	0.000973	0.0087	CbGeAlD
Propiomazine—DRD1—nervous system—autistic disorder	0.000973	0.0087	CbGeAlD
Propiomazine—DRD1—central nervous system—autistic disorder	0.000936	0.00837	CbGeAlD
Propiomazine—CHRM5—brain—autistic disorder	0.000873	0.00781	CbGeAlD
Propiomazine—HRH1—eye—autistic disorder	0.000843	0.00754	CbGeAlD
Propiomazine—HRH1—forebrain—autistic disorder	0.000836	0.00748	CbGeAlD
Propiomazine—CHRM2—head—autistic disorder	0.000827	0.00739	CbGeAlD
Propiomazine—CHRM3—digestive system—autistic disorder	0.000826	0.00738	CbGeAlD
Propiomazine—ADRA1B—brain—autistic disorder	0.000798	0.00713	CbGeAlD
Propiomazine—HTR2C—head—autistic disorder	0.000797	0.00713	CbGeAlD
Propiomazine—CHRM2—nervous system—autistic disorder	0.000784	0.00701	CbGeAlD
Propiomazine—ADRA1D—brain—autistic disorder	0.00078	0.00698	CbGeAlD
Propiomazine—HRH1—telencephalon—autistic disorder	0.000769	0.00687	CbGeAlD
Propiomazine—HTR2C—nervous system—autistic disorder	0.000756	0.00676	CbGeAlD
Propiomazine—CHRM2—central nervous system—autistic disorder	0.000755	0.00675	CbGeAlD
Propiomazine—CHRM1—head—autistic disorder	0.000753	0.00673	CbGeAlD
Propiomazine—DRD1—brain—autistic disorder	0.000743	0.00665	CbGeAlD
Propiomazine—HTR2C—central nervous system—autistic disorder	0.000727	0.0065	CbGeAlD
Propiomazine—HTR2A—brainstem—autistic disorder	0.000723	0.00647	CbGeAlD
Propiomazine—CHRM1—nervous system—autistic disorder	0.000714	0.00638	CbGeAlD
Propiomazine—HTR2A—eye—autistic disorder	0.000704	0.0063	CbGeAlD
Propiomazine—HTR2A—forebrain—autistic disorder	0.000698	0.00624	CbGeAlD
Propiomazine—CHRM1—central nervous system—autistic disorder	0.000687	0.00614	CbGeAlD
Propiomazine—Methadyl Acetate—OPRM1—autistic disorder	0.000676	0.0802	CrCbGaD
Propiomazine—CHRM3—head—autistic disorder	0.000673	0.00602	CbGeAlD
Propiomazine—HTR2A—telencephalon—autistic disorder	0.000642	0.00574	CbGeAlD
Propiomazine—CHRM3—nervous system—autistic disorder	0.000639	0.00571	CbGeAlD
Propiomazine—ADRA1A—head—autistic disorder	0.000618	0.00553	CbGeAlD
Propiomazine—CHRM3—central nervous system—autistic disorder	0.000615	0.0055	CbGeAlD
Propiomazine—DRD2—head—autistic disorder	0.000606	0.00542	CbGeAlD
Propiomazine—CHRM2—brain—autistic disorder	0.000599	0.00536	CbGeAlD
Propiomazine—HRH1—digestive system—autistic disorder	0.000587	0.00525	CbGeAlD
Propiomazine—ADRA1A—nervous system—autistic disorder	0.000586	0.00524	CbGeAlD
Propiomazine—HTR2C—brain—autistic disorder	0.000578	0.00516	CbGeAlD
Propiomazine—DRD2—nervous system—autistic disorder	0.000575	0.00514	CbGeAlD
Propiomazine—ADRA1A—central nervous system—autistic disorder	0.000564	0.00505	CbGeAlD
Propiomazine—DRD2—central nervous system—autistic disorder	0.000553	0.00495	CbGeAlD
Propiomazine—ADRA1A—cerebellum—autistic disorder	0.000552	0.00493	CbGeAlD
Propiomazine—CHRM1—brain—autistic disorder	0.000545	0.00488	CbGeAlD
Propiomazine—DRD2—cerebellum—autistic disorder	0.000541	0.00484	CbGeAlD
Propiomazine—HTR2A—digestive system—autistic disorder	0.00049	0.00438	CbGeAlD
Propiomazine—CHRM3—brain—autistic disorder	0.000488	0.00436	CbGeAlD
Propiomazine—HRH1—head—autistic disorder	0.000479	0.00428	CbGeAlD
Propiomazine—HRH1—nervous system—autistic disorder	0.000454	0.00406	CbGeAlD
Propiomazine—ADRA1A—brain—autistic disorder	0.000448	0.00401	CbGeAlD
Propiomazine—DRD2—brain—autistic disorder	0.000439	0.00393	CbGeAlD
Propiomazine—HRH1—central nervous system—autistic disorder	0.000437	0.00391	CbGeAlD
Propiomazine—HTR2A—head—autistic disorder	0.0004	0.00357	CbGeAlD
Propiomazine—Diltiazem—CACNA1C—autistic disorder	0.000393	0.0466	CrCbGaD
Propiomazine—HTR2A—nervous system—autistic disorder	0.000379	0.00339	CbGeAlD
Propiomazine—HTR2A—central nervous system—autistic disorder	0.000365	0.00326	CbGeAlD
Propiomazine—HTR2A—cerebellum—autistic disorder	0.000357	0.00319	CbGeAlD
Propiomazine—Acetophenazine—DRD1—autistic disorder	0.000357	0.0423	CrCbGaD
Propiomazine—HRH1—brain—autistic disorder	0.000347	0.0031	CbGeAlD
Propiomazine—Propericiazine—DRD1—autistic disorder	0.000315	0.0373	CrCbGaD
Propiomazine—Levomethadyl Acetate—OPRM1—autistic disorder	0.000294	0.0349	CrCbGaD
Propiomazine—HTR2A—brain—autistic disorder	0.00029	0.00259	CbGeAlD
Propiomazine—Trifluoperazine—XDH—autistic disorder	0.00027	0.032	CrCbGaD
Propiomazine—Trimipramine—HTR3A—autistic disorder	0.000253	0.03	CrCbGaD
Propiomazine—Trimipramine—HTR1D—autistic disorder	0.00025	0.0297	CrCbGaD
Propiomazine—Methadone—HTR3A—autistic disorder	0.00024	0.0284	CrCbGaD
Propiomazine—Triflupromazine—DRD1—autistic disorder	0.000219	0.0259	CrCbGaD
Propiomazine—Levomethadyl Acetate—CYP19A1—autistic disorder	0.000208	0.0247	CrCbGaD
Propiomazine—Clomipramine—GSTP1—autistic disorder	0.000203	0.0241	CrCbGaD
Propiomazine—Acepromazine—DRD1—autistic disorder	0.000202	0.024	CrCbGaD
Propiomazine—Thioproperazine—DRD1—autistic disorder	0.000198	0.0234	CrCbGaD
Propiomazine—Mesoridazine—DRD3—autistic disorder	0.000196	0.0232	CrCbGaD
Propiomazine—Thiothixene—DRD1—autistic disorder	0.000195	0.0231	CrCbGaD
Propiomazine—Pipotiazine—DRD1—autistic disorder	0.000195	0.0231	CrCbGaD
Propiomazine—Prochlorperazine—DRD3—autistic disorder	0.000189	0.0225	CrCbGaD
Propiomazine—Methadone—OPRM1—autistic disorder	0.000173	0.0205	CrCbGaD
Propiomazine—Cyamemazine—HTR2A—autistic disorder	0.000172	0.0203	CrCbGaD
Propiomazine—Fluphenazine—DRD3—autistic disorder	0.000171	0.0203	CrCbGaD
Propiomazine—Fluphenazine—DRD1—autistic disorder	0.000168	0.0199	CrCbGaD
Propiomazine—Chlorprothixene—DRD3—autistic disorder	0.000156	0.0185	CrCbGaD
Propiomazine—Chlorprothixene—DRD1—autistic disorder	0.000153	0.0181	CrCbGaD
Propiomazine—Thioridazine—DRD1—autistic disorder	0.000145	0.0172	CrCbGaD
Propiomazine—Methotrimeprazine—DRD3—autistic disorder	0.000141	0.0167	CrCbGaD
Propiomazine—Methotrimeprazine—DRD1—autistic disorder	0.000138	0.0164	CrCbGaD
Propiomazine—Perphenazine—DRD1—autistic disorder	0.000133	0.0158	CrCbGaD
Propiomazine—Methadone—CYP19A1—autistic disorder	0.000122	0.0145	CrCbGaD
Propiomazine—Promazine—DRD1—autistic disorder	0.00012	0.0142	CrCbGaD
Propiomazine—Acepromazine—HTR2A—autistic disorder	0.00011	0.0131	CrCbGaD
Propiomazine—Clomipramine—SLC6A4—autistic disorder	0.000109	0.0129	CrCbGaD
Propiomazine—Thioproperazine—HTR2A—autistic disorder	0.000108	0.0128	CrCbGaD
Propiomazine—Chlorpromazine—DRD3—autistic disorder	0.000107	0.0127	CrCbGaD
Propiomazine—Thiothixene—HTR2A—autistic disorder	0.000106	0.0126	CrCbGaD
Propiomazine—Pipotiazine—HTR2A—autistic disorder	0.000106	0.0126	CrCbGaD
Propiomazine—Chlorpromazine—DRD1—autistic disorder	0.000105	0.0125	CrCbGaD
Propiomazine—Mesoridazine—HTR2A—autistic disorder	0.000105	0.0124	CrCbGaD
Propiomazine—Trimipramine—SLC6A4—autistic disorder	0.0001	0.0119	CrCbGaD
Propiomazine—Fluphenazine—HTR2A—autistic disorder	9.16e-05	0.0109	CrCbGaD
Propiomazine—Clomipramine—HTR2A—autistic disorder	8.38e-05	0.00993	CrCbGaD
Propiomazine—Chlorprothixene—HTR2A—autistic disorder	8.34e-05	0.00989	CrCbGaD
Propiomazine—Thioridazine—HTR2A—autistic disorder	7.89e-05	0.00936	CrCbGaD
Propiomazine—Trimipramine—HTR2A—autistic disorder	7.71e-05	0.00914	CrCbGaD
Propiomazine—Methotrimeprazine—HTR2A—autistic disorder	7.54e-05	0.00893	CrCbGaD
Propiomazine—Promethazine—HTR2A—autistic disorder	7.42e-05	0.0088	CrCbGaD
Propiomazine—Trifluoperazine—HTR2A—autistic disorder	7.32e-05	0.00868	CrCbGaD
Propiomazine—Perphenazine—HTR2A—autistic disorder	7.24e-05	0.00859	CrCbGaD
Propiomazine—Promazine—HTR2A—autistic disorder	6.53e-05	0.00774	CrCbGaD
Propiomazine—Chlorpromazine—HTR2A—autistic disorder	5.75e-05	0.00681	CrCbGaD
Propiomazine—ADRA1B—Signaling Pathways—HTR2A—autistic disorder	7.32e-06	3.58e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—APOE—autistic disorder	7.32e-06	3.58e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—IL2—autistic disorder	7.31e-06	3.58e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—EGF—autistic disorder	7.31e-06	3.58e-05	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—IL2—autistic disorder	7.3e-06	3.58e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MEF2C—autistic disorder	7.29e-06	3.57e-05	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—IL2—autistic disorder	7.29e-06	3.57e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MEF2C—autistic disorder	7.28e-06	3.56e-05	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—IL2—autistic disorder	7.26e-06	3.56e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TSC2—autistic disorder	7.26e-06	3.56e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MEF2C—autistic disorder	7.26e-06	3.55e-05	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—IL2—autistic disorder	7.24e-06	3.55e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—SERPINE1—autistic disorder	7.24e-06	3.54e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MEF2C—autistic disorder	7.23e-06	3.54e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—ITGB3—autistic disorder	7.22e-06	3.54e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IGF1—autistic disorder	7.2e-06	3.53e-05	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—IL2—autistic disorder	7.17e-06	3.51e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—MAPK1—autistic disorder	7.17e-06	3.51e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MEF2C—autistic disorder	7.16e-06	3.51e-05	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—IL2—autistic disorder	7.15e-06	3.5e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MEF2C—autistic disorder	7.14e-06	3.5e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—SERPINE1—autistic disorder	7.14e-06	3.5e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—POMC—autistic disorder	7.13e-06	3.49e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—ITGB3—autistic disorder	7.11e-06	3.48e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—APOE—autistic disorder	7.1e-06	3.48e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—LEP—autistic disorder	7.1e-06	3.48e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—ITGB3—autistic disorder	7.09e-06	3.47e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—ITGB3—autistic disorder	7.07e-06	3.46e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—ITGB3—autistic disorder	7.05e-06	3.45e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—POMC—autistic disorder	7.04e-06	3.45e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—ITGB3—autistic disorder	6.98e-06	3.42e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—ITGB3—autistic disorder	6.96e-06	3.41e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TSC2—autistic disorder	6.95e-06	3.4e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IGF1—autistic disorder	6.86e-06	3.36e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—SERPINE1—autistic disorder	6.84e-06	3.35e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—MAPK1—autistic disorder	6.83e-06	3.34e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—APOE—autistic disorder	6.8e-06	3.33e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—LEP—autistic disorder	6.8e-06	3.33e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IGF1—autistic disorder	6.77e-06	3.32e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HTR2A—autistic disorder	6.74e-06	3.3e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—IL2—autistic disorder	6.74e-06	3.3e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—MAPK1—autistic disorder	6.74e-06	3.3e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PRKCB—autistic disorder	6.7e-06	3.28e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—IL2—autistic disorder	6.63e-06	3.25e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HTR2A—autistic disorder	6.62e-06	3.24e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—IL2—autistic disorder	6.62e-06	3.24e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—PIK3CG—autistic disorder	6.6e-06	3.23e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HTR2A—autistic disorder	6.6e-06	3.23e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—IL2—autistic disorder	6.6e-06	3.23e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HTR2A—autistic disorder	6.58e-06	3.22e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—IL2—autistic disorder	6.58e-06	3.22e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—SERPINE1—autistic disorder	6.52e-06	3.19e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HTR2A—autistic disorder	6.52e-06	3.19e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—IL2—autistic disorder	6.51e-06	3.19e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HTR2A—autistic disorder	6.5e-06	3.18e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—IL2—autistic disorder	6.49e-06	3.18e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—SERPINE1—autistic disorder	6.43e-06	3.15e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PRKCB—autistic disorder	6.41e-06	3.14e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PIK3CG—autistic disorder	6.41e-06	3.14e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—APC—autistic disorder	6.41e-06	3.14e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TSC2—autistic disorder	6.41e-06	3.14e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—EGF—autistic disorder	6.34e-06	3.1e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TSC2—autistic disorder	6.3e-06	3.09e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TSC2—autistic disorder	6.29e-06	3.08e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—POMC—autistic disorder	6.28e-06	3.08e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TSC2—autistic disorder	6.27e-06	3.07e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—APOE—autistic disorder	6.27e-06	3.07e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—LEP—autistic disorder	6.27e-06	3.07e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TSC2—autistic disorder	6.25e-06	3.06e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TSC2—autistic disorder	6.19e-06	3.03e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TSC2—autistic disorder	6.17e-06	3.02e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—LEP—autistic disorder	6.17e-06	3.02e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—APOE—autistic disorder	6.17e-06	3.02e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—LEP—autistic disorder	6.16e-06	3.01e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—APOE—autistic disorder	6.16e-06	3.01e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—APC—autistic disorder	6.14e-06	3.01e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PIK3CG—autistic disorder	6.14e-06	3.01e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—LEP—autistic disorder	6.14e-06	3.01e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—APOE—autistic disorder	6.14e-06	3.01e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—APOE—autistic disorder	6.12e-06	3e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—LEP—autistic disorder	6.12e-06	3e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—POMC—autistic disorder	6.1e-06	2.99e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—HRAS—autistic disorder	6.09e-06	2.98e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—EGF—autistic disorder	6.07e-06	2.97e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—LEP—autistic disorder	6.06e-06	2.97e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—APOE—autistic disorder	6.06e-06	2.97e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—LEP—autistic disorder	6.04e-06	2.96e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—APOE—autistic disorder	6.04e-06	2.96e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—HRAS—autistic disorder	6.01e-06	2.94e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PRKCB—autistic disorder	5.91e-06	2.9e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IGF1—autistic disorder	5.87e-06	2.87e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—IL2—autistic disorder	5.86e-06	2.87e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—MAPK1—autistic disorder	5.84e-06	2.86e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—POMC—autistic disorder	5.84e-06	2.86e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—IL6—autistic disorder	5.83e-06	2.85e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PRKCB—autistic disorder	5.82e-06	2.85e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PRKCB—autistic disorder	5.81e-06	2.84e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PRKCB—autistic disorder	5.79e-06	2.83e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—IL2—autistic disorder	5.78e-06	2.83e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PRKCB—autistic disorder	5.77e-06	2.82e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—HRAS—autistic disorder	5.75e-06	2.82e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—IL6—autistic disorder	5.75e-06	2.82e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PRKCB—autistic disorder	5.71e-06	2.8e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PRKCB—autistic disorder	5.7e-06	2.79e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—APC—autistic disorder	5.66e-06	2.77e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PIK3CG—autistic disorder	5.66e-06	2.77e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IGF1—autistic disorder	5.62e-06	2.75e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—EGF—autistic disorder	5.59e-06	2.74e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—MAPK1—autistic disorder	5.59e-06	2.74e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—SERPINE1—autistic disorder	5.57e-06	2.73e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—APC—autistic disorder	5.57e-06	2.73e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PIK3CG—autistic disorder	5.57e-06	2.73e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—APC—autistic disorder	5.56e-06	2.72e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PIK3CG—autistic disorder	5.56e-06	2.72e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PIK3CG—autistic disorder	5.54e-06	2.71e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—APC—autistic disorder	5.54e-06	2.71e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IL2—autistic disorder	5.53e-06	2.71e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PIK3CG—autistic disorder	5.52e-06	2.7e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—APC—autistic disorder	5.52e-06	2.7e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—PTEN—autistic disorder	5.51e-06	2.7e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—IL6—autistic disorder	5.51e-06	2.7e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—EGF—autistic disorder	5.5e-06	2.7e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—EGF—autistic disorder	5.49e-06	2.69e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—HRAS—autistic disorder	5.48e-06	2.69e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—EGF—autistic disorder	5.47e-06	2.68e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—APC—autistic disorder	5.47e-06	2.68e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PIK3CG—autistic disorder	5.47e-06	2.68e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—EGF—autistic disorder	5.46e-06	2.67e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—APC—autistic disorder	5.45e-06	2.67e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PIK3CG—autistic disorder	5.45e-06	2.67e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—PTEN—autistic disorder	5.44e-06	2.66e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—HRAS—autistic disorder	5.41e-06	2.65e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—EGF—autistic disorder	5.4e-06	2.65e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—EGF—autistic disorder	5.39e-06	2.64e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—POMC—autistic disorder	5.39e-06	2.64e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—SERPINE1—autistic disorder	5.34e-06	2.61e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—POMC—autistic disorder	5.3e-06	2.6e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—POMC—autistic disorder	5.29e-06	2.59e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IL2—autistic disorder	5.27e-06	2.58e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—POMC—autistic disorder	5.27e-06	2.58e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—POMC—autistic disorder	5.25e-06	2.57e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—IL6—autistic disorder	5.25e-06	2.57e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—PTEN—autistic disorder	5.21e-06	2.55e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IL2—autistic disorder	5.2e-06	2.55e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—POMC—autistic disorder	5.2e-06	2.55e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—POMC—autistic disorder	5.19e-06	2.54e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IGF1—autistic disorder	5.18e-06	2.54e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—IL6—autistic disorder	5.18e-06	2.54e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—MAPK1—autistic disorder	5.16e-06	2.53e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IGF1—autistic disorder	5.1e-06	2.5e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IGF1—autistic disorder	5.09e-06	2.49e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—MAPK1—autistic disorder	5.07e-06	2.48e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IGF1—autistic disorder	5.07e-06	2.48e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—MAPK1—autistic disorder	5.06e-06	2.48e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IGF1—autistic disorder	5.05e-06	2.48e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—MAPK1—autistic disorder	5.05e-06	2.47e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—MAPK1—autistic disorder	5.03e-06	2.46e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—PTGS2—autistic disorder	5.01e-06	2.45e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IGF1—autistic disorder	5.01e-06	2.45e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IGF1—autistic disorder	4.99e-06	2.44e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—MAPK1—autistic disorder	4.98e-06	2.44e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—MAPK1—autistic disorder	4.97e-06	2.43e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—PTEN—autistic disorder	4.96e-06	2.43e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—SERPINE1—autistic disorder	4.92e-06	2.41e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—PTEN—autistic disorder	4.9e-06	2.4e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—SERPINE1—autistic disorder	4.84e-06	2.37e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—SERPINE1—autistic disorder	4.83e-06	2.37e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—SERPINE1—autistic disorder	4.82e-06	2.36e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—SERPINE1—autistic disorder	4.8e-06	2.35e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—SERPINE1—autistic disorder	4.75e-06	2.33e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—SERPINE1—autistic disorder	4.74e-06	2.32e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—HRAS—autistic disorder	4.69e-06	2.3e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IL2—autistic disorder	4.51e-06	2.21e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—HRAS—autistic disorder	4.49e-06	2.2e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—IL6—autistic disorder	4.49e-06	2.2e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—MAPK1—autistic disorder	4.48e-06	2.19e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—MAPK1—autistic disorder	4.42e-06	2.17e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—PTEN—autistic disorder	4.37e-06	2.14e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IL2—autistic disorder	4.32e-06	2.12e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—IL6—autistic disorder	4.3e-06	2.1e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PTEN—autistic disorder	4.25e-06	2.08e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—MAPK1—autistic disorder	4.23e-06	2.07e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—HRAS—autistic disorder	4.14e-06	2.03e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—HRAS—autistic disorder	4.07e-06	1.99e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—HRAS—autistic disorder	4.06e-06	1.99e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PTEN—autistic disorder	4.06e-06	1.99e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—HRAS—autistic disorder	4.05e-06	1.98e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—HRAS—autistic disorder	4.04e-06	1.98e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—MAPK1—autistic disorder	4.03e-06	1.98e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—HRAS—autistic disorder	4e-06	1.96e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—HRAS—autistic disorder	3.99e-06	1.95e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IL2—autistic disorder	3.98e-06	1.95e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—MAPK1—autistic disorder	3.98e-06	1.95e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—IL6—autistic disorder	3.96e-06	1.94e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IL2—autistic disorder	3.92e-06	1.92e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IL2—autistic disorder	3.91e-06	1.91e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—IL6—autistic disorder	3.9e-06	1.91e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IL2—autistic disorder	3.9e-06	1.91e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—IL6—autistic disorder	3.89e-06	1.91e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IL2—autistic disorder	3.88e-06	1.9e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—IL6—autistic disorder	3.88e-06	1.9e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—IL6—autistic disorder	3.87e-06	1.89e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IL2—autistic disorder	3.85e-06	1.88e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IL2—autistic disorder	3.84e-06	1.88e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—IL6—autistic disorder	3.83e-06	1.87e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—IL6—autistic disorder	3.82e-06	1.87e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PTEN—autistic disorder	3.75e-06	1.83e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PTEN—autistic disorder	3.69e-06	1.81e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PTEN—autistic disorder	3.68e-06	1.8e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PTEN—autistic disorder	3.67e-06	1.8e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PTEN—autistic disorder	3.66e-06	1.79e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PTEN—autistic disorder	3.62e-06	1.77e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PTEN—autistic disorder	3.61e-06	1.77e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—HRAS—autistic disorder	3.6e-06	1.76e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—HRAS—autistic disorder	3.55e-06	1.74e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—MAPK1—autistic disorder	3.45e-06	1.69e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—IL6—autistic disorder	3.44e-06	1.69e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—HRAS—autistic disorder	3.4e-06	1.66e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—IL6—autistic disorder	3.4e-06	1.66e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MAPK1—autistic disorder	3.3e-06	1.62e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IL6—autistic disorder	3.25e-06	1.59e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—HRAS—autistic disorder	3.24e-06	1.59e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—HRAS—autistic disorder	3.2e-06	1.57e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IL6—autistic disorder	3.1e-06	1.52e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IL6—autistic disorder	3.06e-06	1.5e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MAPK1—autistic disorder	3.05e-06	1.49e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MAPK1—autistic disorder	3e-06	1.47e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MAPK1—autistic disorder	2.99e-06	1.46e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MAPK1—autistic disorder	2.98e-06	1.46e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MAPK1—autistic disorder	2.97e-06	1.46e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MAPK1—autistic disorder	2.94e-06	1.44e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MAPK1—autistic disorder	2.93e-06	1.44e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HRAS—autistic disorder	2.77e-06	1.36e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HRAS—autistic disorder	2.65e-06	1.3e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IL6—autistic disorder	2.65e-06	1.3e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IL6—autistic disorder	2.54e-06	1.24e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HRAS—autistic disorder	2.45e-06	1.2e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—HRAS—autistic disorder	2.41e-06	1.18e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HRAS—autistic disorder	2.4e-06	1.18e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HRAS—autistic disorder	2.39e-06	1.17e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HRAS—autistic disorder	2.39e-06	1.17e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HRAS—autistic disorder	2.36e-06	1.16e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HRAS—autistic disorder	2.36e-06	1.15e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IL6—autistic disorder	2.34e-06	1.15e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IL6—autistic disorder	2.3e-06	1.13e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IL6—autistic disorder	2.3e-06	1.13e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IL6—autistic disorder	2.29e-06	1.12e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IL6—autistic disorder	2.28e-06	1.12e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IL6—autistic disorder	2.26e-06	1.11e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IL6—autistic disorder	2.25e-06	1.1e-05	CbGpPWpGaD
